
Shares of BioXcel Therapeutics Inc (NASDAQ:BTAI) are trading higher Tuesday morning, reversing sharply following earlier weakness, after the company announced its financial results for the second quarter. Here’s what investors need to know.
What To Know: The biopharmaceutical firm reported a net loss of $19.2 million, or a loss of $2.45 per share, for the quarter ended June 30. This marks a wider loss compared to the $8.3 million net loss recorded in the same period of the previous year.